FLT201 clinical trials

Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)

This study is checking on the long-term health of people with Type 1 Gaucher disease who previously received a treatment called FLT201 in an earlier trial. We'll follow them for five years to see how they're doing.